Perrigo Fuels “Growth Engine” With Spending On New Product Pipeline
This article was originally published in The Tan Sheet
Executive Summary
Perrigo plans to file more than 10 abbreviated new drug applications before July this year, President and CEO Joe Papa said Feb. 5